Sex differences in outcomes from mild traumatic brain injury eight years post-injury.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2022
Historique:
received: 03 09 2021
accepted: 16 05 2022
entrez: 27 5 2022
pubmed: 28 5 2022
medline: 1 6 2022
Statut: epublish

Résumé

The long-term effects of mild TBI (mTBI) are not well understood, and there is an ongoing debate about whether there are sex differences in outcomes following mTBI. This study examined i) symptom burden and functional outcomes at 8-years post-injury in males and females following mTBI; ii) sex differences in outcomes at 8-years post-injury for those aged <45 years and ≥45 years and; iii) sex differences in outcomes for single and repetitive TBI. Adults (≥16 years at injury) identified as part of a population-based TBI incidence study (BIONIC) who experienced mTBI 8-years ago (N = 151) and a TBI-free sample (N = 151) completed self-report measures of symptoms and symptom burden (Rivermead Post-Concussion Symptom Questionnaire, Hospital Anxiety and Depression Scale, Post-traumatic Stress Disorder Checklist), and functional outcomes (Participation Assessments with Recombined Tools, Work Limitations Questionnaire). The mTBI group reported significantly greater post-concussion symptoms compared to the TBI-free group (F(1,298) = 26.84, p<.01, ηp2 = .08). Females with mTBI were twice as likely to exceed clinical cut-offs for post-concussive (X2 (1)>5.2, p<.05, V>.19) and PTSD symptoms (X2(1) = 6.10, p = .014, V = .20) compared to the other groups, and reported their health had the greatest impact on time-related work demands (F(1,171) = 4.36, p = .04, ηp2 = .03. There was no interaction between sex and age on outcomes. The repetitive mTBI group reported significantly greater post-concussion symptoms (F(1,147) = 9.80, p<.01, ηp2 = .06) compared to the single mTBI group. Twice the proportion of women with repetitive mTBI exceeded the clinical cut-offs for post-concussive (X2(1)>6.90, p<.01, V>.30), anxiety (X2(1)>3.95, p<.05, V>.23) and PTSD symptoms (X2(1)>5.11, p<.02, V>.26) compared with males with repetitive TBI or women with single TBI. Thus, at 8-years post-mTBI, people continued to report a high symptom burden. Women with mTBI, particularly those with a history of repetitive mTBI, had the greatest symptom burden and were most likely to have symptoms of clinical significance. When treating mTBI it is important to assess TBI history, particularly in women. This may help identify those at greatest risk of poor long-term outcomes to direct early treatment and intervention.

Identifiants

pubmed: 35622845
doi: 10.1371/journal.pone.0269101
pii: PONE-D-21-27103
pmc: PMC9140230
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0269101

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Neurosurgery. 2009 Nov;65(5):876-82; discussion 882-3
pubmed: 19834399
J Neurotrauma. 2015 Apr 15;32(8):517-26
pubmed: 25222514
Arch Phys Med Rehabil. 2021 Jan;102(1):76-86
pubmed: 33035515
Chiropr Man Therap. 2014 Nov 04;22(1):38
pubmed: 25379171
Arch Phys Med Rehabil. 1992 Jun;73(6):519-26
pubmed: 1622299
Neurol Res. 2019 Jul;41(7):609-623
pubmed: 31007155
Lancet Neurol. 2013 Jan;12(1):53-64
pubmed: 23177532
J Neurotrauma. 2013 Dec 15;30(24):2014-20
pubmed: 23924069
Neuroepidemiology. 2009;32(1):1-3
pubmed: 18997470
J Neurotrauma. 2013 Apr 15;30(8):642-52
pubmed: 23046394
J Head Trauma Rehabil. 2020 Mar/Apr;35(2):E86-E94
pubmed: 31246879
J Head Trauma Rehabil. 2013 Jul-Aug;28(4):337-9
pubmed: 23835854
J Head Trauma Rehabil. 2004 Nov-Dec;19(6):459-81
pubmed: 15602309
Health Serv Insights. 2013 Aug 04;6:61-8
pubmed: 25114561
Brain Inj. 2014;28(13-14):1639-45
pubmed: 25265040
JAMA Netw Open. 2021 Apr 1;4(4):e213046
pubmed: 33822070
Arch Phys Med Rehabil. 2017 Aug;98(8):1560-1566
pubmed: 28188778
J Neurol Neurosurg Psychiatry. 2012 Feb;83(2):217-23
pubmed: 22028384
J Affect Disord. 2009 Apr;114(1-3):94-102
pubmed: 18656266
J Head Trauma Rehabil. 2007 Nov-Dec;22(6):318-29
pubmed: 18025964
Med Care. 2001 Jan;39(1):72-85
pubmed: 11176545
Clin Neuropsychol. 2019 Aug;33(6):1016-1043
pubmed: 30618335
J Affect Disord. 2018 Aug 15;236:164-171
pubmed: 29738951
Geroscience. 2021 Feb;43(1):263-278
pubmed: 33070278
J Head Trauma Rehabil. 2010 Mar-Apr;25(2):72-80
pubmed: 20234226
J Neurol. 1995 Sep;242(9):587-92
pubmed: 8551320
Psychiatry Res. 2013 Dec 30;210(3):1301-3
pubmed: 24135551
J Neurotrauma. 2021 Jan 15;38(2):235-251
pubmed: 32838645
BMJ. 2000 Jun 17;320(7250):1631-5
pubmed: 10856063
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
J Neurotrauma. 2012 Jul 20;29(11):2038-49
pubmed: 22414023
PLoS One. 2018 Jan 31;13(1):e0191655
pubmed: 29385179
PLoS One. 2017 Apr 11;12(4):e0174847
pubmed: 28399158
NeuroRehabilitation. 2014;34(4):741-8
pubmed: 24796434
J Neurotrauma. 2001 Jul;18(7):657-64
pubmed: 11497092
Lancet Neurol. 2017 Jul;16(7):532-540
pubmed: 28653646
Arch Phys Med Rehabil. 2014 Mar;95(3 Suppl):S132-51
pubmed: 24581902
Brain Inj. 2019;33(8):1078-1086
pubmed: 31032649
Lancet Neurol. 2017 Dec;16(12):987-1048
pubmed: 29122524
Br J Gen Pract. 2016 Jan;66(642):e16-23
pubmed: 26719482
J Clin Med. 2021 Jun 02;10(11):
pubmed: 34199591
J Rehabil Med. 2004 Feb;(43 Suppl):28-60
pubmed: 15083870
Sports Med. 2015 Jul;45(7):1027-40
pubmed: 25971368
Am J Phys Med Rehabil. 1994 Apr;73(2):103-11
pubmed: 8148099
Neuroepidemiology. 2012;38(1):18-29
pubmed: 22179412
J Rehabil Med. 2004 Feb;(43 Suppl):113-25
pubmed: 15083875
Front Neurol. 2020 May 19;11:350
pubmed: 32508733
Brain Inj. 2018;32(13-14):1651-1658
pubmed: 30373399
Brain Inj. 2018;32(5):617-626
pubmed: 29446658
Neuroepidemiology. 2015;44(4):255-61
pubmed: 26088707
PM R. 2021 Jun 22;:
pubmed: 34156769
Behav Res Ther. 2005 May;43(5):585-94
pubmed: 15865914
JAMA Neurol. 2019 Sep 01;76(9):1049-1059
pubmed: 31157856
Gen Hosp Psychiatry. 2012 Jul-Aug;34(4):332-8
pubmed: 22460001
J Head Trauma Rehabil. 2009 Sep-Oct;24(5):303-12
pubmed: 19858964
Brain Inj. 2015;29(7-8):859-65
pubmed: 25914943

Auteurs

Nicola Jayne Starkey (NJ)

School of Psychology, University of Waikato, Hamilton, New Zealand.

Brittney Duffy (B)

School of Psychology, University of Waikato, Hamilton, New Zealand.

Kelly Jones (K)

National Institute for Stroke and Applied Neurosciences, School of Clinical Sciences, Auckland University of Technology, Auckland, New Zealand.

Alice Theadom (A)

National Institute for Stroke and Applied Neurosciences, School of Clinical Sciences, Auckland University of Technology, Auckland, New Zealand.

Suzanne Barker-Collo (S)

School of Psychology, University of Auckland, Auckland, New Zealand.

Valery Feigin (V)

National Institute for Stroke and Applied Neurosciences, School of Clinical Sciences, Auckland University of Technology, Auckland, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH